Literature DB >> 26230045

Microparticles Impair Hypotensive Cerebrovasodilation and Cause Hippocampal Neuronal Cell Injury after Traumatic Brain Injury.

Leif-Erik Bohman1, John Riley2, Tatyana N Milovanova3,4, Matthew R Sanborn1, Stephen R Thom3,4, William M Armstead2,5.   

Abstract

Endothelin-1 (ET-1), tissue plasminogen activator (tPA), and extracellular signal-regulated kinases-mitogen activated protein kinase (ERK-MAPK) are mediators of impaired cerebral hemodynamics after fluid percussion brain injury (FPI) in piglets. Microparticles (MPs) are released into the circulation from a variety of cells during stress, are pro-thrombotic and pro-inflammatory, and may be lysed with polyethylene glycol telomere B (PEG-TB). We hypothesized that MPs released after traumatic brain injury impair hypotensive cerebrovasodilation and that PEG-TB protects the vascular response via MP lysis, and we investigated the relationship between MPs, tPA, ET-1, and ERK-MAPK in that process. FPI was induced in piglets equipped with a closed cranial window. Animals received PEG-TB or saline (vehicle) 30-minutes post-injury. Serum and cerebrospinal fluid (CSF) were sampled and pial arteries were measured pre- and post-injury. MPs were quantified by flow cytometry. CSF samples were analyzed with enzyme-linked immunosorbent assay. MP levels, vasodilatory responses, and CSF signaling assays were similar in all animals prior to injury and treatment. After injury, MP levels were elevated in the serum of vehicle but not in PEG-TB-treated animals. Pial artery dilation in response to hypotension was impaired after injury but protected in PEG-TB-treated animals. After injury, CSF levels of tPA, ET-1, and ERK-MAPK were all elevated, but not in PEG-TB-treated animals. PEG-TB-treated animals also showed reduction in neuronal injury in CA1 and CA3 hippocampus, compared with control animals. These results show that serum MP levels are elevated after FPI and lead to impaired hypotensive cerebrovasodilation via over-expression of tPA, ET-1, and ERK-MAPK. Treatment with PEG-TB after injury reduces MP levels and protects hypotensive cerebrovasodilation and limits hippocampal neuronal cell injury.

Entities:  

Keywords:  endothelin; fluid percussion injury; hypotensive cerebrovasodilation; microparticles; tissue plasminogen activator; traumatic brain injury

Mesh:

Substances:

Year:  2015        PMID: 26230045      PMCID: PMC4722602          DOI: 10.1089/neu.2015.3885

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  42 in total

Review 1.  Regulation of the cerebral circulation: role of endothelium and potassium channels.

Authors:  F M Faraci; D D Heistad
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

2.  Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects.

Authors:  S Beppu; H Matsuda; T Shishido; M Matsumura; K Miyatake
Journal:  J Am Soc Echocardiogr       Date:  1997 Jan-Feb       Impact factor: 5.251

3.  Cerebrovascular response in infants and young children following severe traumatic brain injury: a preliminary report.

Authors:  P D Adelson; B Clyde; P M Kochanek; S R Wisniewski; D W Marion; H Yonas
Journal:  Pediatr Neurosurg       Date:  1997-04       Impact factor: 1.162

4.  Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.

Authors:  B Young; J W Runge; K S Waxman; T Harrington; J Wilberger; J P Muizelaar; A Boddy; J W Kupiec
Journal:  JAMA       Date:  1996-08-21       Impact factor: 56.272

Review 5.  Age-dependent cerebral hemodynamic effects of traumatic brain injury in newborn and juvenile pigs.

Authors:  W M Armstead
Journal:  Microcirculation       Date:  2000-08       Impact factor: 2.628

6.  Prostanoids and pial arteriolar diameter in hypotensive newborn pigs.

Authors:  C W Leffler; D W Busija
Journal:  Am J Physiol       Date:  1987-04

7.  Blood pressure and outcome after severe pediatric traumatic brain injury.

Authors:  Monica S Vavilala; Anna Bowen; Arthur M Lam; Joshua C Uffman; Jeffrey Powell; H Richard Winn; Frederick P Rivara
Journal:  J Trauma       Date:  2003-12

8.  Hypotension dilates pial arteries by KATP and kca channel activation.

Authors:  W M Armstead
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

9.  Different cerebral hemodynamic responses following fluid percussion brain injury in the newborn and juvenile pig.

Authors:  W M Armstead; C D Kurth
Journal:  J Neurotrauma       Date:  1994-10       Impact factor: 5.269

10.  Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.

Authors:  P A Grayburn; J L Weiss; T C Hack; E Klodas; J S Raichlen; M A Vannan; A L Klein; D W Kitzman; S G Chrysant; J L Cohen; D Abrahamson; E Foster; J E Perez; G P Aurigemma; J A Panza; M H Picard; B F Byrd; D S Segar; S A Jacobson; D J Sahn; A N DeMaria
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  3 in total

Review 1.  Cellular microparticles and pathophysiology of traumatic brain injury.

Authors:  Zilong Zhao; Yuan Zhou; Ye Tian; Min Li; Jing-Fei Dong; Jianning Zhang
Journal:  Protein Cell       Date:  2017-05-02       Impact factor: 14.870

2.  Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.

Authors:  Alok Kumar; Bogdan A Stoica; David J Loane; Ming Yang; Gelareh Abulwerdi; Niaz Khan; Asit Kumar; Stephen R Thom; Alan I Faden
Journal:  J Neuroinflammation       Date:  2017-03-15       Impact factor: 8.322

3.  The neuroprotective mechanism of sevoflurane in rats with traumatic brain injury via FGF2.

Authors:  Zhongyu Wang; Zhaoyang Wang; Anqi Wang; Juan Li; Junmin Wang; Jingjing Yuan; Xin Wei; Fei Xing; Wei Zhang; Na Xing
Journal:  J Neuroinflammation       Date:  2022-02-17       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.